The company reported third-quarter gains of 24 percent for hip implants, to $6.8 million; 4 percent for knee implants, to $17.3 million; and 7 percent for biologic and spine, to $6.5 million.
Total revenue for the first nine months of 2009 rose 6 percent, to $129 million, over the same period last year.
Read Exactech’s release on third-quarter sales.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
